Globus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. 

CEO
Keith W. Pfeil
CEOKeith W. Pfeil
Employees
5,300
Employees5,300
Headquarters
Audubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded
2003
Founded2003
Employees
5,300
Employees5,300

GMED Key Statistics

Market cap
12.21B
Market cap12.21B
Price-Earnings ratio
29.31
Price-Earnings ratio29.31
Dividend yield
Dividend yield
Average volume
1.10M
Average volume1.10M
High today
$93.63
High today$93.63
Low today
$89.66
Low today$89.66
Open price
$91.09
Open price$91.09
Volume
1.00M
Volume1.00M
52 Week high
$101.40
52 Week high$101.40
52 Week low
$51.79
52 Week low$51.79

Stock Snapshot

The current Globus Medical(GMED) stock price is $90.68, with a market capitalization of 12.21B. The stock trades at a price-to-earnings (P/E) ratio of 29.31.

On 2026-02-01, Globus Medical(GMED) stock traded between a low of $89.66 and a high of $93.63. Shares are currently priced at $90.68, which is +1.1% above the low and -3.2% below the high.

Globus Medical(GMED) shares are trading with a volume of 1M, against a daily average of 1.1M.

In the last year, Globus Medical(GMED) shares hit a 52-week high of $101.40 and a 52-week low of $51.79.

In the last year, Globus Medical(GMED) shares hit a 52-week high of $101.40 and a 52-week low of $51.79.

GMED News

Simply Wall St 1d
Assessing Globus Medical Valuation After Investor Letter Highlights Reaccelerating Spine Growth And Integration Progress

Advertisement Investor letter spotlight and what it suggests for Globus Medical (GMED) Meridian Growth Fund recently called out Globus Medical (GMED) as a key...

Assessing Globus Medical Valuation After Investor Letter Highlights Reaccelerating Spine Growth And Integration Progress
TipRanks 2d
Globus Medical upgraded to Buy from Hold at Needham

Needham upgraded Globus Medical (GMED) to Buy from Hold with a $112 price target Published first on TheFly – the ultimate source for real-time, market-moving b...

TipRanks 2d
Globus Medical upgraded to Buy at Needham on EPS upside potential

As previously reported, Needham analyst David Saxon upgraded Globus Medical (GMED) to Buy from Hold with a $112 price target following the company’s Q4 revenue...

Analyst ratings

65%

of 17 ratings
Buy
64.7%
Hold
29.4%
Sell
5.9%

More GMED News

TipRanks 6d
Globus Medical initiated with a Buy at TD Cowen

TD Cowen initiated coverage of Globus Medical (GMED) with a Buy rating and $110 price target The stock has overcome a lot of negative sentiment, and while many...

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.